Overview

Special Survey of Production of Insulin Aspart Specific Antibody

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Japan. The aim of this study is to collect data of production of insulin aspart specific antibody under normal clinical practice conditions.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Antibodies
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin, Globin Zinc
Insulin, Long-Acting